• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


BD Eyes Expansion of Columbus, Nebraska, Manufacturing Facility

BD (Becton, Dickinson and Company), a leading global medical technology company, started construction on a $60 million upgrade of its East facility in Columbus, Nebraska.

The 69,000 sq. ft. expansion will transform the Columbus-East facility into the flagship plastic injection molding manufacturing facility for BD, and it will become one of the largest and most sophisticated plastic molding plants in the world. The project is expected to be completed by 2021.

"BD is one of the largest users of plastic injection molded products in the world, with hundreds of billions of units produced internally each year," said James Borzi, executive vice President and Chief Supply Chain Officer of BD. "The new facility will centralize a majority of BD's North American plastic molding production and will support multiple business units in the U.S. and around the world."

Laurie Reagan, the plant manager for the new plastic molding facility, said BD plans to invest $7 million to retain and retrain its associates for the different skill sets needed for plastic molding manufacturing, or to facilitate their transfer to its other manufacturing facility in Columbus or other sites across the BD network.

In addition, BD is partnering with Central Community College to create customized curriculum for its retraining needs.

"This is an exciting day for growing the community of Columbus and the State of Nebraska," said Governor Pete Ricketts. "BD's $60 million expansion at their Columbus-East facility is another example of how the industry's faith in our state can help create new opportunities in our communities. With facilities in Columbus, Holdrege, and Broken Bow, BD has been a great partner in growing the Good Life and we appreciate their ongoing investment in Nebraska."

BD also has operations in Holdrege and Broken Bow, Nebraska, and employs approximately 2,500 people across the state. In September 2016, BD announced a $100 million investment in its Holdrege facility to expand its insulin syringe manufacturing operations.

Article Discussion